|
The patient experienced severe itching and drainage from the incision sites.Antibiotics were prescribed, the patient has seen wound care, the itchiness was clearing, the wound was wrapped, and the patient was instructed not to resume therapy until the wounds were completely healed.Additional information was received on july 29, 2026.Although the wounds healed under wound care, the itchiness and drainage continued and the wound opened back up.An explant procedure will be performed.However, a date has not yet been scheduled.No further information is available at this time.
|
|
The surgical issue questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device after the expiration date, not prepping the surface of the skin with an antiseptic solution, multiple tunneling attempts, using incorrect tools, and not prescribing antibiotics pre-operatively have been ruled out.Additionally, surgical issues, implanting the device off-label, the patient having contraindications, and improperly closing the surgical site have been ruled out.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the reported issue is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, the conclusion has been selected as unable to determine the root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in surgical issues.Surgical issue rates remain acceptably low; thus, a capa is not required at this time.Surgical issue rates will continue to be tracked and trended.
|